William Gross - 30 Dec 2021 Form 4/A - Amendment Insider Report for Heliogen, Inc. (HLGN)

Role
CHIEF EXECUTIVE OFFICER, Director
Signature
/s/ Susan Aledort, General Counsel
Issuer symbol
HLGN
Transactions as of
30 Dec 2021
Net transactions value
$0
Form type
4/A - Amendment
Filing time
02 Jun 2022, 16:05:24 UTC
Date Of Original Report
04 Jan 2022
Next filing
15 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HLGN Common Stock Award $0 +1,086,882 $0.000000 1,086,882 30 Dec 2021 See footnote F1
holding HLGN Common Stock 1,589,488 30 Dec 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The securities are held directly by Idealab Studio. Idealab Studio and Mr. Gross may be deemed to share beneficial ownership of the common stock. Idealab Studio and Mr. Gross each disclaims beneficial ownership of such shares except to the extent of his and its pecuniary interest therein.

Remarks:

1. The original Form 4, filed on January 4, 2022, and the Form 4/A, filed on January 7, 2022, are being further amended by this Form 4/A to report indirect ownership of the common stock of Heliogen, Inc. held by Idealab Studio, LLC ("Idealab Studio"). Mr. Gross is currently the Chief Executive Officer and chairman of the board of directors of Idealab Studio. Mr. Gross also holds a majority of the shares with a right to elect 2 of Idealab Studio's 3 directors.